Virginia Kelly
- Genetics top 1%
- Hematology top 2%
- Oncology top 10%
- Molecular Biology
- Pathology and Forensic Medicine top 5%
- Co-authors
- Nadine BessonDong‐Wook KimJörge E. CortesEric LeipH. Jean KhouryCarlo Gambacorti‐PasseriniTim H. BrümmendorfHagop M. Kantarjian
- Topics
- Chronic Lymphocytic Leukemia Research (22 papers)Chronic Myeloid Leukemia Treatments (17 papers)Acute Lymphoblastic Leukemia research (9 papers)
- Partner nations
- United StatesFranceSouth Korea
In The Last Decade
Virginia Kelly
33 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 60
- Genetics 624
- Hematology 453
- Oncology 394
- Molecular Biology 322
- Pathology and Forensic Medicine 316
Countries citing papers authored by Virginia Kelly
This map shows the geographic impact of Virginia Kelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginia Kelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginia Kelly more than expected).
Fields of papers citing papers by Virginia Kelly
This network shows the impact of papers produced by Virginia Kelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginia Kelly. The network helps show where Virginia Kelly may publish in the future.
Co-authorship network of co-authors of Virginia Kelly
This figure shows the co-authorship network connecting the top 25 collaborators of Virginia Kelly. A scholar is included among the top collaborators of Virginia Kelly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginia Kelly. Virginia Kelly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 59 | |
| 2 | 26 | |
| 3 | 183 | |
| 4 | 204 | |
| 5 | 18 | |
| 6 | 54 | |
| 7 | 29 | |
| 8 | 2 | |
| 9 | 9 | |
| 10 | 2 | |
| 11 | 15 | |
| 12 | 26 | |
| 13 | 13 | |
| 14 | 25 | |
| 15 | 32 | |
| 16 | 25 | |
| 17 | 1 | |
| 18 | 2 | |
| 19 | 48 | |
| 20 | 4 |
About Virginia Kelly
Virginia Kelly is a scholar working on Genetics, Hematology and Rheumatology, having authored 34 papers that have together received 1.2k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (22 papers), Chronic Myeloid Leukemia Treatments (17 papers) and Acute Lymphoblastic Leukemia research (9 papers). The work is most often cited by research in Genetics (624 citations), Hematology (453 citations) and Pathology and Forensic Medicine (316 citations). Virginia Kelly has collaborated with scholars based in United States, France and South Korea. Frequent co-authors include Nadine Besson, Dong‐Wook Kim, Jörge E. Cortes, Eric Leip, H. Jean Khoury, Carlo Gambacorti‐Passerini, Tim H. Brümmendorf, Hagop M. Kantarjian, Jennifer Sweeney and Mark Douglas. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.